PyInvesting

Market research

0455.HK Tianda Pharmaceuticals Limited

HK HKD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
277M
P/E ratio
Not available
Analyst target
Not available
Dividend yield
Not available
Beta
-0.06

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Tianda Pharmaceuticals Limited is currently in a long term uptrend where the price is trading 22.6% above its 200 day moving average.

From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.

Tianda Pharmaceuticals Limited's total revenue sank by 6.7% to $123M since the same quarter in the previous year.

Its net income has increased by 18.3% to $786K since the same quarter in the previous year.

Finally, its free cash flow fell by 744.5% to $-31M since the same quarter in the previous year.

Based on the above factors, Tianda Pharmaceuticals Limited gets an overall score of 3/5.